UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $1.3M of United Therapeutics Corporation
Sold$1,290,083
$215.01Price
6,000Shares
−14%Stake
What UTHR did after the filing
- The stock from Mon, Feb 5 open, $214.87
- +11.4%
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Mar 19 close.
Traded Thu, Feb 1. Filed Fri, Feb 2, 4:30 PM ET, after the close. Returns use the Feb 5 open and the Mar 19 close. Not investment advice.